160 related articles for article (PubMed ID: 36528757)
1. Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma.
Sadeghi R; Pirankuraim H; Javanshir ST; Arabi M; Bereimipour A; Javanshir HT; Mahmoodzadeh H; Nayernia K
Eye (Lond); 2023 Aug; 37(11):2327-2334. PubMed ID: 36528757
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
[TBL] [Abstract][Full Text] [Related]
4.
Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
[No Abstract] [Full Text] [Related]
5. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma.
Krishnakumar S; Mallikarjuna K; Desai N; Muthialu A; Venkatesan N; Sundaram A; Khetan V; Shanmugam MP
Br J Ophthalmol; 2004 Dec; 88(12):1521-6. PubMed ID: 15548804
[TBL] [Abstract][Full Text] [Related]
6. Lifetime risks of common cancers among retinoblastoma survivors.
Fletcher O; Easton D; Anderson K; Gilham C; Jay M; Peto J
J Natl Cancer Inst; 2004 Mar; 96(5):357-63. PubMed ID: 14996857
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan.
Zhang Z; Xiao YS; Shen R; Jiang HC; Tan L; Li RQ; Yang XH; Gu HY; He WJ; Ma J
BMC Med Genet; 2020 Nov; 21(1):230. PubMed ID: 33225895
[TBL] [Abstract][Full Text] [Related]
10. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
[TBL] [Abstract][Full Text] [Related]
12. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
14. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis.
Zhang Y; Duan S; Jang A; Mao L; Liu X; Huang G
Exp Eye Res; 2021 Jan; 202():108304. PubMed ID: 33080301
[TBL] [Abstract][Full Text] [Related]
15. Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma.
Torbidoni AV; Laurent VE; Sampor C; Ottaviani D; Vazquez V; Gabri MR; Rossi J; de Dávila MT; Alonso C; Alonso DF; Chantada GL
JAMA Ophthalmol; 2015 Jul; 133(7):805-12. PubMed ID: 25928893
[TBL] [Abstract][Full Text] [Related]
16. Trilateral retinoblastoma: a systematic review and meta-analysis.
de Jong MC; Kors WA; de Graaf P; Castelijns JA; Kivelä T; Moll AC
Lancet Oncol; 2014 Sep; 15(10):1157-67. PubMed ID: 25126964
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation in the presentation of retinoblastoma among 149 patients.
Frenkel S; Zloto O; Sagi M; Fraenkel A; Pe'er J
Exp Eye Res; 2016 May; 146():313-317. PubMed ID: 27068507
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
20. RB1 genetic testing as a clinical service: a follow-up study.
Cohen JG; Dryja TP; Davis KB; Diller LR; Li FP
Med Pediatr Oncol; 2001 Oct; 37(4):372-8. PubMed ID: 11568901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]